Launch research programs to develop and validate sensitive neuropsychological and behavioral assessment measures to detect and track the earliest clinical manifestations of AD and AD-related dementias.
Development of at least one sensitive neuropsychological assessment measure that has been validated for the detection or tracking of the earliest clinical manifestations of AD and AD-related dementias.
Extend ongoing research on social and emotional functioning and decision-making in MCI/AD to identy early behavioral markers of disease.
Support research to develop clinical tools for assessment of early deficits in decision-making, motivation and social and emotional functioning in AD.
2014 to 2022
Research Implementation Area
B. Diagnosis, Assessment and Disease Monitoring